If you have been reading about regulatory status and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2025-12-14. Where a claim depends on a specific study, the study is described rather than over-claimed.
Melanotan II is a synthetic peptide analog modeled on alpha-melanocyte-stimulating hormone, a naturally occurring signaling peptide involved in pigmentation. Its structure is a cyclic heptapeptide containing two non-natural substitutions, norleucine at position four and D-phenylalanine at position seven. These modifications resist enzymatic breakdown and extend the molecule's activity relative to the native hormone. The compound binds melanocortin receptors and is studied mainly as a pharmacological tool rather than a therapeutic product. It has never received approval as a medicine in any major jurisdiction.
The compound was developed in the late 1980s and 1990s by academic researchers investigating photoprotection. The rationale held that stimulating melanin production might reduce ultraviolet damage to skin and lower skin cancer risk. Early work examined receptor binding, pigment response, and short-term tolerability in small studies. That program did not produce an approved drug, and formal development stalled after early-phase trials. Whether induced pigmentation confers meaningful photoprotection remains an open question.
Regulatory treatment of this peptide varies by country. It holds no marketing authorization as a medicine in the United States, the European Union, or most other jurisdictions. Some countries classify products containing it as prescription-only or unlicensed medicines, which restricts lawful supply. Authorities have issued public notices warning that unregulated products may contain undeclared or incorrect ingredients. The molecule also appears on prohibited lists for competitive sport. These measures address supply oversight rather than any approved therapeutic role.
Published research on the compound remains limited. Much of the human data comes from small, early-stage studies rather than large controlled trials, and several questions about effects and variability between individuals remain open. Investigators have examined receptor activity, pigment pathways, and related physiological responses in laboratory and animal models. Findings from those models do not automatically translate to human outcomes. Reviews frequently note the scarcity of rigorous clinical evidence and call for better-characterized study material.
Because the substance circulates mainly through informal markets, verification is a recurring theme in technical discussion. Independent analyses have found that labeled content and actual content can diverge, and that purity varies between samples. Analytical laboratories use reversed-phase chromatography to separate components and mass spectrometry to confirm identity. Isotope-labeled internal standards improve quantification in complex matrices. Such methods describe what a sample contains but say nothing about its sterility, lawful status, or suitability for any use. Open questions remain about how consistently testing is applied across the supply chain.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic cyclic heptapeptide | Belongs to the melanocortin agonist family |
| Key substitutions | Nle4 and D-Phe7 | Improve resistance to enzymatic degradation |
| Molecular formula | C50H69N15O9 | Approximately 1024 g/mol |
| Regulatory status | Not approved as a medicine | Distributed as a research chemical |
| Common synonyms | Melanotan II, MT-II, MT-2 | Spelling varies across sources |
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone. Its sequence incorporates a lactam bridge that constrains the peptide into a ring, which increases resistance to enzymatic breakdown relative to the natural hormone. Researchers at the University of Arizona synthesised the compound in the late 1980s and early 1990s while studying pigmentation pathways. It has never received marketing approval from any national medicines regulator. In the scientific literature it is usually described as a laboratory research reagent rather than a therapeutic product.
The peptide acts as a non-selective agonist at melanocortin receptors, showing affinity for MC1R, MC3R, MC4R and MC5R. Activation of MC1R on melanocytes drives the conversion of tyrosine into melanin and shifts production toward the darker eumelanin form. MC4R signalling in the central nervous system is linked to appetite and energy balance, which helps explain why reduced food intake appeared in early human studies. Effects on MC4R and on vascular tone also account for the erectile responses recorded as unexpected findings in those same trials.
Melanotan II holds no marketing authorisation from the Food and Drug Administration, the European Medicines Agency, the UK Medicines and Healthcare products Regulatory Agency or Australia's Therapeutic Goods Administration. Products sold under that name are treated as unapproved new drugs, and their sale or import is prohibited in several jurisdictions. Other countries classify the peptide as a prescription-only medicine or place it among controlled substances, so the legal position changes with the destination market. No pharmacopoeial monograph supplies an official specification, because the material is not a licensed pharmaceutical. Consequently, products offered online are not manufactured to a shared public standard.
The peer-reviewed record is dominated by small early-phase studies, case reports and pharmacovigilance summaries rather than large randomised trials. Papers typically examine tanning response, receptor selectivity or patterns of reported adverse events. Many note that participants obtained the peptide outside a clinical setting, which limits verification of composition and administered amount. Reported events vary widely, and causality is frequently unclear because the identity and purity of self-sourced material are unknown. Open questions include whether repeated melanocortin receptor stimulation produces cumulative effects, and how often label claims match actual content.
Pharmacologically, melanotan-2 behaves as a non-selective agonist across the melanocortin receptor family. Binding at MC1R on dermal melanocytes promotes eumelanin synthesis, which underlies the tanning response described in early human work. Activity at the centrally expressed MC4R receptor is associated with reported effects on appetite and erectile function. Because the peptide does not discriminate strongly among receptor subtypes, attributing any single observed effect to one receptor pathway is generally not possible without selective antagonists or receptor knockout models.
Research interest has centred on photoprotection and pigmentation, with a smaller body of work on appetite and sexual function. Published human data remain limited to small, frequently uncontrolled studies, and the compound has never received marketing approval from a national medicines regulator. Most laboratory work treats it as a pharmacological tool for probing melanocortin signalling in cell culture or animal models. Whether pigmentation changes observed in people translate into measurable protection against ultraviolet-induced DNA damage remains an open question.
Verification of a purchased sample requires documentation linking a batch to a certificate of analysis, and that document should be read for the methods used rather than the headline purity figure. A single chromatographic percentage does not establish identity. Independent laboratories can perform identity and content assays, but no such test establishes that a product is suitable for human use. Claims about efficacy rest largely on small, early studies rather than on replicated controlled trials, and that gap remains open.
Identity testing for a cyclic peptide of this size usually relies on reversed-phase high-performance liquid chromatography coupled to mass spectrometry. The mass spectrum confirms molecular weight, while the chromatographic trace indicates the proportion of related impurities. Tandem mass spectrometry can provide sequence-level information when fragmentation data are compared against a reference standard. Nuclear magnetic resonance is sometimes used to confirm the lactam bridge, although it requires more material and greater operator expertise than routine chromatographic methods.
Lyophilised peptide powder is comparatively stable when kept dry, cold and protected from light. Once dissolved, the molecule is exposed to hydrolysis, oxidation and microbial growth, and degradation accelerates at higher temperatures and in alkaline solution. Repeated freeze-thaw cycles concentrate solutes and promote aggregation. Handling guidance for research peptides commonly clusters around freezer temperatures for powder and short refrigerated use for reconstituted solutions, with pH control and sterile technique applied throughout.
Major subranges of the Eastern Front include the Black Mountains, Great Craggy Mountains, and Great Balsam Mountains, and its chief summits include Grandfather Mountain 5,964 ft (1,818 m) near the Tennessee-North Carolina border, Mount Mitchell 6,684 ft (2,037 m) in the Blacks, and Black Balsam Knob 6,214 ft (1,894 m) and Cold Mountain 6,030 ft (1,840 m) in the Great Balsams. The Western Blue Ridge Front is subdivided into the Unaka Range, the Bald Mountains, the Great Smoky Mountains, and the Unicoi Mountains, and its major peaks include Roan Mountain 6,285 ft (1,916 m) in the Unakas, Big Bald 5,516 ft (1,681 m) and Max Patch 4,616 ft (1,407 m) in the Bald Mountains, Kuwohi 6,643 ft (2,025 m), Mount Le Conte 6,593 feet (2,010 m), and Mount Guyot 6,621 ft (2,018 m) in the Great Smokies, and Big Frog Mountain 4,224 ft (1,287 m) near the Tennessee-Georgia-North Carolina border. Prominent summits in the cross ridges include Waterrock Knob (6,292 ft (1,918 m)) in the Plott Balsams. Across northern Georgia, numerous peaks exceed 4,000 ft (1,200 m), including Brasstown Bald, the state's highest, at 4,784-and-4,696 ft (1,458-and-1,431 m) Rabun Bald. In north-central Alabama, Mount Cheaha rises prominently to 1,445 feet (440 m) over its surroundings, as part of the southernmost spur of the Blue Ridge Mountains.
Other stressors that can stimulate increased solanine biosynthesis include mechanical damage, improper storage conditions, improper food processing, and sprouting. The largest concentration of solanine in response to stress is on the surface in the peel, making it an even better defense mechanism against pests trying to consume it.
=== Environmental and food safety tests === Paper-based microfluidic devices have several applications outside of the medical field. For example, paper-based biosensors have been used extensively in environmental monitoring. Two recent devices were developed for the detection of Salmonella and E. coli. The latter device was specifically used to detect E. coli in seven field water samples from Tucson, Arizona. Antibody-conjugated polystyrene particles were loaded in the middle of the microfluidic channel, after the sample inlet. Immunoagglutination occurs when samples containing Salmonella or E. coli, respectively, come into contact with these particles. The amount of immunoagglutination can be correlated with increased Mie scattering of light, which was detected with a specialized smartphone application under ambient light. Paper-based microfluidics has also been used to detect pesticides in food products, such as apple juice and milk. A recent design used piezoelectric inkjet printing to imprint paper with the enzyme acetylcholinesterase (AChE) and the substrate indophenyl acetate (IPA), and this paper-based microfluidic device was used to detect organophosphate pesticides (AChE inhibitors) via a decrease in blue-purple color. This device is distinguished by its use of bioactive paper instead of compartments with pre-stored reagents, and it was demonstrated to have good long-term stability, making it ideal for field use.
Sources: en.wikipedia.org
East Point's Greatest Hit is the only solo studio album by American rapper Cool Breeze. It was released on March 23, 1999, via Organized Noize/A&M Records. The recording sessions took place at the Dungeon Recording Studio, the Chamber Recording Studios and Purple Dragon Recording Studios in SWATS, Sound Chamber Recorders in Los Angeles and the Boom Boom Room in Augusta. It was produced by Organized Noize, Mr. DJ, 2 Cold Capone and Skinny Miracles. It features guest appearances from Witchdoctor, 8Ball, Backbone, Big Rube, Goodie Mob, Kurupt, Nivea, Outkast, Sleepy Brown and the Calhouns. The album peaked at number 38 on the Billboard 200 and number 11 on the Top R&B/Hip-Hop Albums in the United States. Its lead single, a Dungeon Family posse cut "Watch for the Hook", made it to No. 73 on the US Billboard Hot 100.
A mortar attack by insurgents killed six civilians and wounded 14 whereas two policemen were injured by sniper fire during the operation in Hangu, following which Pakistani forces took control of the area. Two children were killed and four were injured in crossfire during a skirmish in Bajaur District. On 7-8 May 2026, Pakistani forces conducted two operations in Dera Ismail Khan and Tank District, killing five militants. On 8 May 2026, eight civilians were injured in a quadcopter strike in Bannu District. A police constable was killed by militants after his abduction in Bajaur. On 9 May 2026, a car bomb exploded at a Pakistani checkpoint in Bannu, leaving at least 21 dead. Ittehad-ul-Mujahideen Pakistan, a Pakistani Taliban splinter group, claimed responsibility for the attack. On 10 May 2026, an Al-Qaeda affiliate was arrested by CTD in Pakpattan District. Pakistani forces killed seven militants including two key commanders, and destroyed militant infrastructure in a clearance operation in North Waziristan District. On 11 May 2026, a civilian was killed while foiling a suicide bombing in Attock District. On 12 May 2025, UNAMA stated that 372 civilians were killed and 397 had been wounded in Pakistani strikes on Afghanistan. On 13 May 2026, nine people including two traffic police personnel were killed and 33 injured in a VBIED attack by TTP in Lakki Marwat District, TTP militants also blew up a bridge in Bannu District. TTP militants captured a bank van and robbed PKR 80M. CM Khyber Pakhtunkhwa claimed that 80% of militants operating in the province were foreigners.
The kidney is a vital organ with a variety of responsibilities. It plays an important role in maintaining the water, electrolyte and acid-base balance. It excretes toxic metabolic degradation products such as urea. It also recovers valuable substances such as glucose, amino acids, peptides and minerals initially filtered out of the blood during ultrafiltration in the renal corpuscles. In addition, endogenous and exogenous substances are metabolized and broken down in the kidneys—the kidney is therefore a central metabolic organ alongside the liver. Finally, some hormone-active substances are secreted by the kidney, such as renin, erythropoietin and calcitriol (active form of vitamin D3). As a result, the organ plays an important role in the regulation of blood pressure, new blood formation and the balance of calcium and phosphorus, and is thus crucial to bone metabolism, as well. As carnivores, cats are particularly dependent on the intake of animal proteins because glucose formation from amino acids is their most important energy source. The enzymes of amino acid degradation are adapted to the high protein intake and their activity is largely independent of the protein supply in the diet, so that cats break down endogenous proteins (especially from the muscles) when there is a lack of protein intake (catabolic metabolic state). Meat and offal also contain vital nutrients for the cat, such as Vitamin A, Taurin or arachidonic acid. Compared to a normal human diet, cats consume around six times as much phosphate in their diet with standard cat food.
Sources: en.wikipedia.org
Transamination is a chemical reaction that transfers an amino group from an amino acid to an α-keto acid. This process mainly takes place in the liver. In the liver, amino groups from different amino acids are transferred to α-ketoglutarate to form glutamate. In the mitochondria, glutamate is deaminated and toxic ammonium enters the urea cycle for excretion. Another site of transamination is the skeletal muscles. In the skeletal muscles, amino groups are transferred to pyruvate, forming alanine. Alanine carries nitrogen to the liver through the glucose–alanine cycle. In biochemistry, the process occurs extensively during amino acid synthesis and is catalyzed by transaminases (aminotransferases), which requires the cofactor pyridoxal phosphate (PLP), and an α-keto acid as the acceptor of the amino group. α-ketoglutarate acts as the predominant amino-group acceptor and produces glutamate.
Models Four-door saloon (called the Protegé in North America, 323S in Europe, 323 Protegé in Australia, 323 Lantis/Familia in Indonesia, Allegro in Colombia, Artis in Chile and Étude in South Africa) Three-door coupé hatchback (Familia Neo in Japan, 323C in Europe and 323 in Canada) Three-door hatchback (called the 323P in Europe)
On July 29, 1977, H.F., a 51-year-old teacher, was attempting to remove a casserole dish from her new 600-watt microwave oven. The oven signaled the end of the heating cycle, but the light and the cooking blower were on. During retrieval of the dish, she inserted two thirds of her bare forearms into the oven, for a total time of about five seconds. The oven was still operating. She felt "hot pulsating sensation" and burning in fingers and fingernails and a sensation of "needles" over the exposed areas. Jabbing pain, swelling, and red-orange discoloration of dorsal sides of both hands and forearms appeared shortly afterwards. The next day she sought medical help. Since then, she has undergone treatment with oral and topical cortisone, Grenz rays, ultrasound, and later acupuncture, without relief. Symptoms persisted, including high sensitivity to radiant heat (sun, desk lamp, etc.) and growing intolerance to pressure of clothes and to touch in hands and forearms. Neurological examinations in 1980 and 1981 did not yield a definite diagnosis. Neuronal latencies were within norm. Electromyography discovered denervation in the median nerve, ulnar nerve, and radial nerve on both arms. Severe reduction of number of sweat glands in the finger pulps, in comparison with a random control, was also found.
Sources: en.wikipedia.org
It is a synthetic cyclic peptide designed as an analog of alpha-melanocyte-stimulating hormone. It acts on melanocortin receptors and is best known from research into pigmentation. It is not an approved pharmaceutical product.
No regulatory agency has approved it for any indication. It is encountered as a research chemical sold outside pharmaceutical supply chains. Products marketed this way are not subject to the manufacturing and labeling requirements that apply to approved drugs.
Reports describe increased skin pigmentation as well as side effects such as nausea, flushing, and changes to existing moles. Much of the evidence comes from small studies and case reports rather than large trials. The long-term safety profile is therefore uncertain.
Only a small number of early-stage human studies have been reported, and most were limited in size and duration. No large late-stage program has established a general efficacy or safety profile. The evidence base is therefore thin compared with approved medicines.